Cartesian Growth Corporation III Unit Stock Price: Quote, Forecast, Splits & News (CGCTU)

IPO Activity Surges as Cartesian Growth Corp III Raises $240 Million

May 2, 2025

Cartesian Growth Corp III has successfully completed its upsized initial public offering, raising $240 million by issuing 24 million units at $10 each. The SPAC, led by Peter Yu, targets high-growth businesses for merger or acquisition. Units began trading on Nasdaq under the symbol CGCTU.

Investor Interest Steady in Cartesian Growth Corp III Post-IPO

May 14, 2025

Trading in Cartesian Growth Corp III (CGCTU) units has remained stable since its May 2 debut, with prices hovering around $10.01 to $10.03 and significant daily volumes. The SPAC’s performance reflects ongoing investor confidence as it searches for an initial business combination.

Biotech Spotlight: Cartesian Therapeutics to Present at BioConnect Conference

Cartesian Therapeutics, focused on cell therapies for autoimmune diseases, will participate in the H.C. Wainwright BioConnect Investor Conference at Nasdaq on May 20. The company’s lead asset, Descartes-08, is advancing to Phase 3 trials for generalized myasthenia gravis, signaling momentum in its clinical pipeline.

Go Deeper

Related

Go Deeper